Rani Therapeutics elects Lyn Baranowski to Board, grants 31,695 stock options

Rani Therapeutics Holdings, Inc.

Lyn Baranowski elected as Director effective Nov 10, 2021; term expires at next annual meeting.
Appointed to Compensation Committee and Nominating and Corporate Governance Committee.
Granted options to purchase 31,695 shares of Class A common stock at $26.78 (closing price on grant date).
Options vest over 3 years: one-third at first anniversary, then monthly installments, subject to continuous service.
Ms. Baranowski has no arrangement with others for her election, and no material interest in transactions requiring disclosure.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Lyn Baranowski

Director

RANI · Rani Therapeutics Holdings, Inc.

Effective: 2021-11-10
Filed: November 12, 2021, 6:59 PM ET

On November 10, 2021, upon the recommendation of its Nominating and Corporate Governance Committee, the board of directors (the “Board”) of Rani Therapeutics Holdings, Inc. (the “Company”) elected Lyn Baranowski as a Director, effective immediately, with a term expiring at the Company’s next annual meeting of stockholders.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Lyn Baranowski was elected as Director at Rani Therapeutics Holdings, Inc..

Action: elected
Role: Director

Exact text from the filing

On November 10, 2021, upon the recommendation of its Nominating and Corporate Governance Committee, the board of directors (the “Board”) of Rani Therapeutics Holdings, Inc. (the “Company”) elected Lyn Baranowski as a Director, effective immediately, with a term expiring at the Company’s next annual meeting of stockholders.

View on SEC.gov

Rani Therapeutics Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-21-328226

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.